Abstract: A disinfecting device for a handheld instrument is provided. The disinfecting device includes a receptacle having a cavity for supporting a portion of the handheld instrument, a germicide comprising an amount effective to disinfect the handheld instrument, and a germicidal carrier such that a portion of the handheld instrument contacts the germicide when the portion of the handheld instrument is supported in the receptacle. A disinfecting device for a fingertip is also provided. The disinfecting device includes a germicide effective to disinfect the fingertip, a support base having a cavity within the support base for containing the germicide, and a germicidal carrier for retaining germicide such that at least a portion of the fingertip contacts the germicide upon touching the germicidal carrier.

Abstract: An apparatus for deactivating medical instruments and devices, comprised of a decontamination chamber dimensioned to receive medical instruments and devices to be microbially deactivated. A circulation system is provided to circulate a deactivating fluid through the deactivation chamber. The circulation system has a first fluid path connected to the decontamination chamber and a second fluid path is connected to the first fluid path. A water inlet line introduces water into the apparatus. The water inlet line is connected to the second fluid path. A filter is disposed within the second fluid path to filter fluid within the apparatus. A first pump is disposed in the first fluid path to circulate fluid in the first fluid path. A second pump is disposed in the second fluid path to circulate fluid in the second fluid path.

Abstract: A method for separating germanium-68 from gallium-68 using an anion exchange resin and a chelating/complexing agent containing a plurality of carboxylic acid groups and at least three carbon atoms to the first solution is disclosed together with a generator apparatus for providing a source of gallium-68.

Abstract: The present invention relates to a method for producing metal-containing amine solutions by reacting a metal or metal-containing compound, in particular, copper or a copper-containing compound, with an amine, carbon dioxide and an oxidizing agent. The resulting metal-amine solution can then be used to formulate a variety of metal-based wood preserving products.

Abstract: The present invention relates to a catalyst useful for removal of hydrogen sulphide from gas streams and its conversion to sulphur, a process for preparing such catalyst and a method for removing of hydrogen sulphide using said catalyst.

Abstract: An object of the present invention is to provide a catalyst for treating exhaust gas adapted not only to remove CO and VOCs based on unsaturated hydrocarbons such as C2H4 but also to accelerate a decomposition reaction of saturated hydrocarbons such as propane and to provide a method for producing such a catalyst for treating exhaust gas. The present invention provides a catalyst for treating an exhaust gas containing carbon monoxide and volatile organic compounds, the catalyst comprising a substrate containing a NOx removal catalyst component and a porous inorganic compound layer containing a noble metal, the layer being applied to the substrate.

Abstract: Heterogeneous catalyst systems, methods of making these systems, and methods of using these systems, wherein catalytically active gold is deposited onto composite support media. The composite support media is formed by providing nanoporous material on at least a portion of the surfaces of carbonaceous host material. In representative embodiments, relatively fine, nanoporous guest particles are coated or otherwise provided on surfaces of relatively coarser activated carbon particles. Catalytically active gold may be deposited onto one or both of the guest or host materials either before or after the guest and host materials are combined to from the composite host material. PVD is the preferred catalyst system of depositing gold.

Abstract: A method for preparing a LixMyPO4 compound having an olivine structure includes: preparing a solution containing transition metal M ions, Li+ ions and PO43? ions; drying the solution to form particles of a starting material; and forming the particles of the starting material into particles of the LixMyPO4 compound with an olivine structure, in which 0.8?x?1.2 and 0.8?y?1.2, and coating the particles of the LixMyPO4 compound with a carbon layer thereon.

Abstract: A hollow carbon nanoballoon structure having a relatively large closed space, and a method of producing a carbon nanoballoon structure capable of easily and stably producing such a structure. The carbon nanoballoon structure is obtained by heating soot prepared by arc discharge using carbon electrodes, soot prepared by vaporizing. carbon by laser irradiation, or carbon black having a specific surface area of 1000 m2/g or more and a primary particle diameter of 20 nm or more at a high temperature in an inert gas atmosphere, and includes graphite sheets linked to form a curved surface.

Abstract: Disclosed is method for separating solute from an aqueous solution comprising providing a first aqueous solution substantially saturated with solute, contacting the first aqueous solution with a clathrate former under conditions sufficient to form clathrates and to precipitate the solute from the first aqueous solution, separating solute from the clathrates by removing a first stream comprising clathrates and solute, and removing a second stream comprising solute, decomposing the clathrates into the clathrate former and a second aqueous solution, the second aqueous solution comprising solute in a concentration less than the concentration of solute in the first aqueous solution, and recycling the second aqueous solution by contacting said solution with a source for the solute to form a third substantially saturated aqueous solution for use as, or in combination with, the first aqueous solution, wherein the method is continuous.

Abstract: An apparatus for the recovery of a halogen or pseudohalogens from a halide compound in solution; wherein the apparatus includes an electrochemical cell including, an electrode assembly including at least a first and second electrodes in communication with a controller for providing a current to at least two of the electrodes; wherein, upon delivery of a predetermined voltage, the halide compound is oxidised at one or more of the electrodes to form a halogen corresponding to the halide in solution whereupon the halogen is deposited on said one or more electrode upon completion of oxidation.

Abstract: Methods of producing nanoporous particles by spray pyrolysis of a precursor composition including a reactive precursor salt and a nonreactive matrix salt are provided, wherein the matrix salt is used as a templating medium. Nanoporous aluminum oxide particles produced by the methods are also provided.

Abstract: An apparatus and method for generating hydrogen by hydrolytic reaction and supplying the hydrogen to a user device, such as a fuel cell. Water is selectively supplied to a reactor vessel containing supply of an aluminum composite reactive material to produce the hydrolytic reaction. Hydrogen from the reaction vessel is supplied to at least one metal hydride buffer vessel at a relatively high pressure, and is released from the buffer vessel to the user device at a relatively low pressure. In the case of fuel cells, the relatively low pressure is less than the maximum allowable supply pressure of the cell, obviating potential damage thereto. The hydrogen flow may be switched alternately between a plurality of buffer vessels, so that one vessel is being charged at the relatively higher pressure while the other is releasing hydrogen to the fuel cell at the relatively low pressure.

Abstract: Novel peptides and pharmaceutical compositions comprising the same are disclosed. Conjugated compositions peptides linked to detectable agents and/or cytotoxic agents. are disclosed. Method of detecting tumors that have p185 on tumor cell surfaces are disclosed. Methods of preventing transformation of a normal cell into a tumor cell in an individual at risk of developing a tumor having tumor cells which have p185 on their surfaces are disclosed. Methods of treating an individual who has cancer characterized by tumor cells that have a p185 on their cell surfaces are disclosed.

Abstract: A cycloalkyl triamine pentacarboxylate compound coordinating to a metal ion to form a high stability metal complex in serum is provided. The metal complex of the present invention can be used as a contrast agent for magnetic resonance imaging (MRI).

Abstract: An anti-inflammatory analgesic adhesive patch which has an excellent anti-inflammatory analgesic effect and is reduced in unpleasant irritant feeling during wear. It is characterized by containing, as active ingredients, benzocaine and an ingredient having a counter-irritation effect, wherein the ingredient having a counter-irritation effect comprises one or more members selected from the group consisting of 1-menthol, d1-menthol, d1-camphor, d-camphor, methyl salicylate, glycol salicylate, peppermint oil, eucalyptus oil, capsaicin, capsicum extract, and nonylic acid vanillamide and the benzocaine is contained in an amount of 0.5 to 20 wt. %.

Abstract: Pharmaceutical compositions and dosage forms comprising an adsorbent, and an adverse agent, such as an opioid antagonist. In one embodiment, at least a portion of the adverse agent is on the surface or within the micropore structure of an adsorbent material. The pharmaceutical compositions and dosage forms comprising the adsorbent and the adverse agent are useful for preventing or discouraging tampering, abuse, misuse or diversion of a dosage form containing an active pharmaceutical agent, such as an opioid. The present invention also relates to methods for treating a patient with such a dosage form, as well as kits containing such a dosage form with instructions for using the dosage form to treat a patient. The present invention further relates to process for preparing such pharmaceutical compositions and dosage forms.

Abstract: The invention provides immunogenic compositions for mucosal delivery comprising capsular saccharides from at least two of serogroups A, C, W135 and Y of N. meningitidis. It is preferred that the capsular saccharides in the compositions of the invention are conjugated to carrier protein(s) and/or are oligosaccharides. Conjugated oligosaccharide antigens are particularly preferred. The invention also provides immunogenic compositions comprising (a) a capsular saccharide antigen from serogroup C of N. meningitidis, and (b) a chitosan adjuvant. The composition preferably comprises (c) one or more further antigens and/or (d) one or more further adjuvants. The compositions are particularly suitable for mucosal delivery, including intranasal delivery. The use of chitosan and/or detoxified ADP-ribosylating toxin adjuvants enhances anti-meningococcal mucosal immune responses and can shift the Th1/Th2 bias of the responses.

Abstract: A sterile nebulizer formulation contains formoterol and budesonide in about 2 ml or less of saline and is for treatment of COPD and asthma and other airways diseases and disorders.

Abstract: The present invention is directed towards a composition for highly efficient and quick plaque and tartar removal and inhibition including pure ascorbic acid crystals and/or granulars (vitamin C) and an enamel repairing composition such as hydroxyapatite. The composition can contain from about 10% up to 90% of ascorbic acid without compromising the tooth enamel because hydroxyapatite will repair any damage to the enamel. The composition can be used as dental powder, toothpaste, mouthwash, mouth spray and chewing gum in order to cover a wide range of consumers in different settings.

Abstract: The present invention is directed to the use of a compound having the formula wherein R1, R2, R3, R4, L1, and L2 are defined herein. The compounds of the present invention are useful as inhibitors of certain taste perceptions and functions. The invention is also directed to compositions comprising a compound according to the above formula.

Abstract: Thermally responsive compositions that include a thermally responsive viscosity modifier, a polymerizable component, and water are provided. The compositions, which optionally may be hardened, are useful for application to a surface of a body.

Abstract: The present invention is directed to a compound which induces a physiological dispersion response in bacterial cells in a biofilm. The present invention is also directed to compositions containing this compound, methods of isolating the compound, and uses thereof.

Abstract: Disclosed herein is a nail varnish comprising a cosmetically acceptable medium and at least one thixotropic thickener, wherein the composition has a viscosity at 25° C. of at least 0.6 Pa·s. Also disclosed herein is a cosmetic nail makeup process comprising lowering the viscosity of a nail varnish composition with a viscosity at 25° C. of at least 0.6 Pa·s, with a non-chemical action, for instance, a mechanical action, simultaneously with or prior to the application of the composition to the nails.

Abstract: Animal or human hair or nails, eyelashes or eyebrows are treated with internal wool lipid extract.

Abstract: The present invention provides an antioxidant and a whitening agent having high safety, and a external preparation for skin using the same. The antioxidant and whitening agent comprise, as an effective component, one or more extracts from Basidiomycetes selected from the group consisting of Pleurotus abalonus, Pholiota squarrosa, Onnia orientalis, Astraeus hygrometricus and Pleurotus nebrodensis. These extracts have a free radical capturing ability and are useful for suppressing skin oxidation and for preventing and improving skin aging. In addition, the extracts have a tyrosinase activity inhibiting action and can suppress the melanin generation. Since the fruit bodies of these Basidiomycetes have been used for edible purpose and have high safety, they can be used preferably for an external preparation for skin.

Abstract: The invention relates to a cosmetic composition for creating a cosmetic coating having a metallic and multicolored iridescent appearance, comprising a liquid phase and a PVD aluminum pigment, wherein said PVD aluminum pigment has diffractive structures containing from approximately 5,000 to approximately 20,000 structural elements per cm and a metallic aluminum content of from 90% to 100% by weight, based on the weight of the aluminum pigment, and is present in the cosmetic composition at a pigmentation level of from 1.0 to 8.0% by weight, based on the total weight of the cosmetic composition. The invention further relates to an artificial fingernail.

Abstract: The invention is directed to a process for disguising hair loss by selecting a cosmetic pigmentation to match the color of existing hair; disbursing the cosmetic pigmentation onto the scalp epidermis in the thinning hair area; and blending the cosmetic pigmentation to uniformly cover the scalp epidermis in the thinning hair area.

Abstract: A cosmetic composition for use on hair, skin or nails, containing a safe and effective amount of boron nitride powder has been found which improves the appearance of skin by blurring lines and wrinkles while at the same time providing coverage of age spots, blemishes and other discolorations.

Abstract: A topical composition with a sustained softness feel to the skin, comprising an effective amount of boron nitride suspended in a dermatologically acceptable carrier vehicle, wherein the composition suitably adheres to the skin, leaving a coating layer comprising boron nitride particles. The present invention also relates to a method of massaging by applying the composition of the present invention on the body part to be massaged, and massaging the part coated with the composition of the invention.

Abstract: The present invention is directed to a water-in-oil emulsion composition comprising: a lipophilic personal care composition comprising by weight: (a) from about 1% to about 30% of a polyglycerin fatty acid ester having a polyglycerin of 2-20 units and at least one branched fatty acid residue of 8 to 22 carbons; (b) from about 0.01% to about 6% of glycerin, wherein the amount of glycerin is no more than 20% of the polyglycerin fatty acid ester; (c) from about 0.001% to no more than an amount dissolvable in glycerin of a water-soluble skin benefit agent; and (d) a lipophilic carrier which is substantially free of surfactant.

Abstract: An antimicrobial composition consists essentially of a substituted polyhydric alcohol and a fatty acid ester, the composition having the structure: wherein R? is H, CH3, CH2— (O[CH2]n)z—OH, or and wherein x+y, x+y+z or w+x+y+z, or combinations thereof, has an average value ranging from about 6 to about 100; R is a hydrocarbon comprising from about 3 to about 19 carbons; n is an integer ranging from about 2 to about 4 or combinations thereof; m is an integer ranging from 0 to about 6. The composition is water soluble, being characterized by an HLB value greater than 10; can be used in formulations, such as cosmetics, household and personal care products, pharmaceuticals and pet care products. Personal care products include sanitizers, lotions, shampoos, anhydrous gels, sunscreens, hair products, moisturizing products, and cleansers.

Abstract: Cosmetic and/or toiletry formulations having novel preservative blends including isothiazolinone and vicinal diols which are liquid at room temperature. The formulations provide antimicrobial properties including unexpectedly enhanced antifungal properties.

Abstract: A cosmetically acceptable composition comprising from about 0.1 to about 10 weight percent, based on polymer solids, of a water-soluble ampholyte polymer comprising: from at least 1 to as much as 95 weight percent of the nonionic monomer acrylamide; from at least 5 to as much as 80 weight percent of the cationic monomer dimethyldiallylammonium chloride; from at least 1 to as much as 75 weight percent of the anionic monomer acrylic acid, is disclosed. The application of these polymers to a keratinous substance is also disclosed. In addition, a method of treating a keratinous substance comprising applying a cosmetically acceptable composition comprising from about 0.

Abstract: A water-in-oil emulsion is provided in which the lipophilic phase of the emulsion contains a silicone fluid and an emulsifier, a hydrophilic phase, and a pharmaceutically active compound. The active pharmaceutical ingredient is dissolved or dispersed in the emulsion and is partitioned in the emulsion so that all or a portion of the amount of the chemical compound dissolved or dispersed in the emulsion is dissolved or dispersed in the aqueous phase of the emulsion. The emulsion of the invention provides increased penetration into skin of the chemical compound dissolved or dispersed in the aqueous phase.

Abstract: A process of producing cellooligosaccharide, comprising enzymatically decomposing, in the presence of cellulase, a water-insoluble natural cellulosic material having an average degree of polymerization not greater than 700, an average particle size not greater than 100. A process of producing cellooligosaccharide, comprising enzymatically decomposing, in the presence of cellulase, a water-insoluble natural cellulosic material having an average degree of polymerization not greater than 700, containing 10% or more by mass of a colloidal cellulose component and a diethyl ether-soluble substance content less than 1% by mass.

Abstract: A personal care composition comprising: a) a synthetic random copolymer having a net positive charge comprising; i.) a nonionic monomer unit of the following formula: where R is H or C1-4 alkyl; and R1 and R2 are independently selected from the group consisting of H, C1-4 alkyl, CH2OCH3, CH2OCH2CH(CH3)2, and phenyl, or together are C3-6cycloalkyl; and ii.) a cationic monomer unit with 2 or more positive charges of the following formula: where k=1, each of v, v?, and v? is independently an integer of from 1 to 6, w is zero or an integer of from 1 to 10, and X? is an anion. and; b) a detersive surfactant; and c) an aqueous carrier.

Abstract: This invention is a topical tyrosinase inhibiting combination using alpha arbutin and bearberry extract, in synergism, for the purpose of skin lightening. The active admixture is a dermatological serum comprised of alpha arbutin, octyl stearate and polyolprepolymer-2, introduced onto the human skin in liposome form for ultra-deep penetration.

Abstract: A process for producing a solubilized keratin of utility value easily with high yield while suppressing coloration and smelling occurring in the hydrolysis of keratin. There is provided a process for producing a solubilized keratin, characterized in that it comprises regulating the water content of keratin raw material to a hydrous state of 20 to 80%, hydrolyzing the same in an alkali solution, neutralizing the hydrolyzate liquid, and extracting a keratin hydrolyzate from the supernatant.

Abstract: The present invention relates to a composition for treating acne comprising an anti-microbial peptide made from the amino acids phenylalanine, alanine, leucine and lysine with said peptide admixed with salicylic acid and/or salicylate salts in a cosmetic delivery vehicle containing a rehydrating polymer. The invention further relates to a method for treating acne by topically administering one of the compositions in an amount therapeutically effective to reduce the redness and blemishes associated with acne.

Abstract: Disclosed herein are personal care and cosmetic compositions comprising 1,3-propanediol, wherein the 1,3-propanediol in said personal care or cosmetic composition has a bio-based carbon content of about 1% to 100%. In addition, it is preferred that the 1,3-propanediol be biologically-derived, and wherein upon biodegradation, the biologically-derived 1,3-propanediol contributes no anthropogenic CO2 emissions to the atmosphere.

Abstract: Disclosed herein is a composition for promoting hair growth. The composition comprises an Asiasari Radix extract as an active ingredient wherein the Asiasari Radix extract exhibits superior induction of the anagen phase of the hair growth cycle. The composition exhibits excellent hair loss prevention and hair growth promoting effects. In particular, when the composition further comprises an inhibitor of 5?-reductase activity and an activator of hair follicle cells, it exhibits better hair loss prevention and hair growth promoting effects.

Abstract: A system is disclosed consisting of tea tree oil used alone or in combination with conventional over-the-counter strength anti-acne agents. A system is created whereby Tea tree oil is used in combination with other anti-acne therapies, particularly benzoyl peroxide. Subsequent steps utilize conventional anti-acne treatments.

Abstract: Ophthalmic compositions comprising at least one antioxidant agent chosen from a carotenoid, glutathione, reduced glutathione, glutathione enhancers, a lipoic acid, a flavonoid, an oleanoic acid, ascorbyl palmitate, aloe vera extract, an omega-6 fatty acid, melatonin, and vitamin E acetate.

Abstract: A composition for use on the skin includes a carbomer, a starch, vitamins, moisturizers, an astringent, a Pluronic, dimethicone, and an aluminum compound. The composition may further include water, glycerin, emulsifiers, and surfactants. The composition provides therapeutic, conditioning, and other benefits to the skin, particularly when used on the hands, and is compatible with the use of gloves, including latex gloves.

Abstract: The present invention provides surface modification methods of pancreatic islet membranes by polymeric grafting. Particularly, the present invention provides the surface modification methods that hydrophilic polymer chain is grafted onto collagen membranes of the pancreatic islets by various polymeric grafting methods instead of encapsulation of the pancreatic islets. Since the surface modification methods of the present invention minimize immunorejection without islet damage in islet transplantation, extend efficiency and survival time of the pancreatic islets by maintaining a high diffusion rate of oxygen and nutrient and reduce total volume of the pancreatic islets required for islet transplantation, they can be effectively used for transplantation of the pancreatic islets.

Abstract: Due to the poor long-term clinical outcome in the adult patients with several forms of acute leukemia novel treatment strategies are needed to overcome resistance and sensitize the leukemia blasts to the extrinsic and intrinsic pathway of apoptosis. Treatment with LAQ824 and Apo-2L/TRAIL alone has been recognized to induce apoptosis of leukemia blasts but intrinsic mechanisms of resistance limit the antileukemia activity of either agent when administered alone. The inventive method overcomes the resistance to current apoptosis inducing treatments demonstrated by AML and CML-BC cells by concomitantly administering Apo-2L/TRAIL with the histone deacetylase inhibitor LAQ824.

Abstract: This invention relates to up-regulation of the acetyltransferase MCM3AP by the administration of the cytokines TNFalpha and IL-6 and, optionally a deacetylase inhibitor. This up-regulation is shown herein to be selectively lethal to cancer cells and has applications in the treatment of cancer.

Abstract: Methods of treating, preventing and/or managing macular degeneration are disclosed. Specific embodiments encompass the administration of a selective cytokine inhibitory drug, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.

Abstract: The present invention discloses compositions and a method of improving the pharmacokinetics of pharmaceutical agents (or pharmaceutically acceptable salts, esters, and prodrugs thereof) which are metaboilized by cytochrome P450 monoxygenase comprising coadministering ritonavir or a pharmaceutically acceptable salt, ester, and prodrug thereof.